FDA Approves Ustekinumab for Children With IBD

Originally published by our sister publication Gastroenterology & Endoscopy NewsBy Katie PrinceThe FDA has approved ustekinumab (Stelara, Johnson & Johnson) for the treatment of children as young as 2 years of age with moderate to severe ulcerative colitis.Ustekinumab, which was approved to treat moderate to severe Crohn’s disease in this population in April, is the first biologic non–tumor necrosis factor inhibitor approved for pediatric patients with inflammatory bowel dise